Seattle Genetics To Webcast Investor And Analyst Event At American Society of Hematology Annual Meeting

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that the company will webcast an investor and analyst event on Monday, December 7, 2015 during the 57th American Society of Hematology (ASH) Annual Meeting in Orlando, FL. Members of Seattle Genetics’ management team and an industry expert will discuss data being presented at the conference from multiple programs, most notably ADCETRIS® (brentuximab vedotin), SGN-CD33A (vadastuximab talirine) and SGN-CD19A (denintuzumab mafodotin).

Back to news